US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Therapeutics

39.68

-0.3200-0.80%

Post-market: 39.28-0.4000-1.01%19:57 EDT

Volume:614.67K

Turnover:24.44M

Market Cap:1.13B

PE:-20.90

High:40.50

Open:40.00

Low:38.82

Close:40.00

52wk High:41.70

52wk Low:16.54

Shares:28.52M

Float Shares:13.13M

Volume Ratio:1.16

T/O Rate:4.68%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.8984

EPS(LYR):-2.3387

ROE:-26.25%

ROA:-18.44%

PB:5.48

PE(LYR):-16.97

Loading ...

Overview Company News Filings

BriaCell Therapeutics Says Board Approved Share Consolidation

MT Newswires Live

Dermata Therapeutics Is Maintained at Buy by Maxim Group

Dianthus Therapeutics Is Maintained at Outperform by Wedbush

Keros Therapeutics Shareholder ADAR1 Capital Urges Board to 'Work Collaboratively'

MT Newswires Live

Ocumension Therapeutics Reports Strong Revenue Growth Amid Product Expansion

Lisata Therapeutics Price Target Maintained With a $15.00/Share by HC Wainwright & Co.

Trevi Therapeutics Initiated at Overweight by Morgan Stanley

Wedbush Raises Price Target on Dianthus Therapeutics to $42 From $34, Keeps Outperform Rating

MT Newswires Live

Werewolf Therapeutics price target lowered to $3 from $4 at Citizens JMP

IRLAB Therapeutics Appoints Roy Jonebrant as Interim CFO

Trevi Therapeutics initiated with an Overweight at Morgan Stanley

Goldman Sachs Reviews Viking Therapeutics (VKTX.US) Oral Drug VK2735 Trial Results: Significant Efficacy but Questionable Tolerability, Better Suited for Weight Maintenance

Chimeric Therapeutics Director Acquires Significant Shareholding

Tryptamine Therapeutics Enters Exclusive Agreement for Development of Proprietary Electroencephalogram-Based Biomarker Platform

MT Newswires Live

Private equity firms in Ocumension Therapeutics (HKG:1477) are its biggest bettors, and their bets paid off as stock gained 5.5% last week

Simply Wall St.

Tryptamine Therapeutics Announces Proposed Issue of Securities

Silexion Therapeutics Executes Reverse Stock Split

Trevi Therapeutics CFO Resignation Announced

Oruka Therapeutics initiated with a Buy at Clear Street

Windtree Therapeutics to Be Delisted from NASDAQ for Failing to Meet Minimum Closing Price Standards

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/LENZ/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LENZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LENZ\",,,,,undefined,":{"symbol":"LENZ","market":"US","secType":"STK","nameCN":"Therapeutics","latestPrice":39.68,"timestamp":1756152000000,"preClose":40,"halted":0,"volume":614667,"hourTrading":{"tag":"盘后","latestPrice":39.28,"preClose":39.68,"latestTime":"19:57 EDT","volume":3541,"amount":140244.06,"timestamp":1756166236694},"delay":0,"floatShares":13134810,"shares":28522096,"eps":-1.898372,"marketStatus":"Closed","change":-0.32,"latestTime":"08-25 16:00:00 EDT","open":40,"high":40.5,"low":38.815,"amount":24435960.578265,"amplitude":0.042125,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.898372,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1756195200000},"marketStatusCode":5,"adr":0,"listingDate":1624593600000,"exchange":"NASDAQ","adjPreClose":40,"preHourTrading":{"tag":"盘前","latestPrice":40,"preClose":40,"latestTime":"09:27 EDT","volume":300800,"amount":12031724.467200002,"timestamp":1756128420047},"postHourTrading":{"tag":"盘后","latestPrice":39.28,"preClose":39.68,"latestTime":"19:57 EDT","volume":3541,"amount":140244.06,"timestamp":1756166236694},"volumeRatio":1.162023,"impliedVol":0.8322,"impliedVolPercentile":0.7263},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LENZ\",,,,,undefined,":{"symbol":"LENZ","floatShares":13134810,"roa":"-18.44%","roe":"-26.25%","lyrEps":-2.338654,"volumeRatio":1.162023,"shares":28522096,"dividePrice":0,"high":40.5,"amplitude":0.042125,"preClose":40,"low":38.815,"week52Low":16.535,"pbRate":"5.48","psRate":"226.35","week52High":41.7,"institutionHeld":0,"latestPrice":39.68,"eps":-1.898372,"divideRate":0,"volume":614667,"delay":0,"ttmEps":-1.898372,"open":40,"prevYearClose":28.87,"prevWeekClose":40,"prevMonthClose":29.77,"prevQuarterClose":29.31,"fiveDayClose":38.77,"twentyDayClose":31.51,"sixtyDayClose":29.53},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LENZ\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-07-30","symbol":"LENZ","fiscalQuarterEnding":"2025/06","expectedEps":-0.58,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1753848000000,"reportTimeType":"pre","actualEps":-0.53},{"market":"US","date":"2024-05-08","symbol":"LENZ","fiscalQuarterEnding":"2024/03","expectedEps":-0.84,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"pre","actualEps":-3.53},{"market":"US","date":"2024-03-22","symbol":"LENZ","defaultRemindTime":1711114200000,"type":"split","dateTimestamp":1711080000000,"forFactor":7,"toFactor":1,"ratio":7},{"date":"2024-03-22","symbol":"LENZ","amount":1.03,"announcedDate":null,"type":"dividend","market":"US","newRecordDate":"2024-03-18","name":"Therapeutics","recordDate":"2024-03-21","payableDate":"2024-03-18","currency":"USD","dateTimestamp":1711080000000,"payDate":"2024-03-21"},{"market":"US","date":"2021-08-12","symbol":"LENZ","fiscalQuarterEnding":"2021/06","expectedEps":-1.11,"name":null,"time":"","type":"earning","dateTimestamp":1628740800000,"reportTimeType":"","actualEps":-3.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LENZ\",market:\"US\",,,undefined,":[{"executeDate":"2024-03-22","recordDate":"2024-03-18","paymentDate":"2024-03-21","value":1.03,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LENZ\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":8,"updateTime":1742443200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LENZ\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LENZ","date":"2025-08-22","current":-21.691773,"percent":0.002985,"low":-22.268769,"twenty":-16.434778,"median":-11.220775,"eighty":-7.693556,"high":-5.069183,"avg":-11.98188,"sd":4.459531,"marketCap":1136605525},"quantilePoints":[{"date":"2024-03-28","current":-7.959158,"twenty":-7.219077,"median":-6.108955,"eighty":-6.016992,"marketCap":556886354},{"date":"2024-04-05","current":-7.492045,"twenty":-7.873034,"median":-7.667213,"eighty":-6.662191,"marketCap":524203432},{"date":"2024-04-12","current":-7.929963,"twenty":-7.855517,"median":-7.667213,"eighty":-7.432197,"marketCap":554843672},{"date":"2024-04-19","current":-6.382653,"twenty":-7.855517,"median":-7.488396,"eighty":-6.783348,"marketCap":446581492},{"date":"2024-04-26","current":-5.638193,"twenty":-7.716113,"median":-7.451903,"eighty":-5.889996,"marketCap":394493084},{"date":"2024-05-03","current":-5.988527,"twenty":-7.671592,"median":-6.864363,"eighty":-5.803142,"marketCap":419005276},{"date":"2024-05-10","current":-5.317808,"twenty":-7.667213,"median":-6.108955,"eighty":-5.803142,"marketCap":393230653},{"date":"2024-05-17","current":-5.708011,"twenty":-7.597146,"median":-6.0013,"eighty":-5.749862,"marketCap":422084590},{"date":"2024-05-24","current":-5.428308,"twenty":-7.489126,"median":-6.006774,"eighty":-5.719496,"marketCap":401401679},{"date":"2024-05-31","current":-5.355793,"twenty":-7.479638,"median":-5.988527,"eighty":-5.522773,"marketCap":396039443},{"date":"2024-06-07","current":-5.193496,"twenty":-7.457742,"median":-5.904593,"eighty":-5.428999,"marketCap":384038248},{"date":"2024-06-14","current":-6.433167,"twenty":-7.451903,"median":-5.930138,"eighty":-5.428308,"marketCap":475706952},{"date":"2024-06-21","current":-6.236339,"twenty":-7.425628,"median":-5.992177,"eighty":-5.43107,"marketCap":461152311},{"date":"2024-06-28","current":-6.150011,"twenty":-7.389135,"median":-6.0013,"eighty":-5.439358,"marketCap":454768696},{"date":"2024-07-05","current":-6.098214,"twenty":-7.269437,"median":-6.014073,"eighty":-5.469746,"marketCap":450938528},{"date":"2024-07-12","current":-6.771573,"twenty":-6.771573,"median":-6.098214,"eighty":-5.493918,"marketCap":500730721},{"date":"2024-07-15","current":-7.261916,"twenty":-7.163847,"median":-6.103393,"eighty":-5.509112,"marketCap":536989651},{"date":"2024-08-02","current":-8.498134,"twenty":-7.266429,"median":-6.108573,"eighty":-5.524305,"marketCap":628403011},{"date":"2024-08-09","current":-8.328931,"twenty":-7.474529,"median":-6.146558,"eighty":-5.597209,"marketCap":615891126},{"date":"2024-08-16","current":-8.944708,"twenty":-7.671592,"median":-6.236339,"eighty":-5.641258,"marketCap":621424629},{"date":"2024-08-23","current":-8.79431,"twenty":-7.94748,"median":-6.352018,"eighty":-5.670717,"marketCap":610975896},{"date":"2024-08-30","current":-8.746816,"twenty":-8.006409,"median":-6.382653,"eighty":-5.719496,"marketCap":607676296},{"date":"2024-09-06","current":-9.451311,"twenty":-8.199004,"median":-6.419354,"eighty":-5.743293,"marketCap":656620360},{"date":"2024-09-13","current":-8.17293,"twenty":-8.352945,"median":-6.434893,"eighty":-5.773217,"marketCap":567806132},{"date":"2024-09-20","current":-8.7389,"twenty":-8.507104,"median":-6.459289,"eighty":-5.788545,"marketCap":607126363},{"date":"2024-09-27","current":-8.806184,"twenty":-8.638371,"median":-6.616182,"eighty":-5.792924,"marketCap":611800796},{"date":"2024-10-04","current":-8.897214,"twenty":-8.745233,"median":-7.269437,"eighty":-5.800953,"marketCap":618125029},{"date":"2024-10-11","current":-9.340491,"twenty":-8.850511,"median":-7.455552,"eighty":-5.81701,"marketCap":648921294},{"date":"2024-10-18","current":-10.417023,"twenty":-8.905129,"median":-7.492045,"eighty":-5.857882,"marketCap":723712222},{"date":"2024-10-25","current":-9.902504,"twenty":-9.0017,"median":-7.670862,"eighty":-5.904593,"marketCap":687966558},{"date":"2024-10-31","current":-10.939457,"twenty":-9.257377,"median":-7.718702,"eighty":-5.904593,"marketCap":760007820},{"date":"2024-11-08","current":-14.709443,"twenty":-9.419648,"median":-7.959158,"eighty":-5.955683,"marketCap":894466512},{"date":"2024-11-15","current":-15.344855,"twenty":-9.514636,"median":-8.00261,"eighty":-5.970448,"marketCap":933105265},{"date":"2024-11-22","current":-15.521232,"twenty":-9.76398,"median":-8.132103,"eighty":-5.988527,"marketCap":943830613},{"date":"2024-11-29","current":-16.100113,"twenty":-9.924668,"median":-8.17293,"eighty":-5.994366,"marketCap":979031755},{"date":"2024-12-06","current":-16.33076,"twenty":-10.388526,"median":-8.285117,"eighty":-6.004584,"marketCap":993057210},{"date":"2024-12-13","current":-13.920266,"twenty":-10.815972,"median":-8.351032,"eighty":-6.018452,"marketCap":846477455},{"date":"2024-12-20","current":-13.694141,"twenty":-11.182468,"median":-8.50374,"eighty":-6.082845,"marketCap":832727009},{"date":"2024-12-27","current":-14.476534,"twenty":-12.093039,"median":-8.531114,"eighty":-6.098214,"marketCap":880303552},{"date":"2025-01-03","current":-12.794163,"twenty":-13.449021,"median":-8.618187,"eighty":-6.102358,"marketCap":778000234},{"date":"2025-01-10","current":-11.912274,"twenty":-13.190334,"median":-8.707238,"eighty":-6.108649,"marketCap":724373495},{"date":"2025-01-17","current":-10.130408,"twenty":-13.019383,"median":-8.746816,"eighty":-6.115785,"marketCap":616019980},{"date":"2025-01-24","current":-11.197719,"twenty":-12.871045,"median":-8.79431,"eighty":-6.143105,"marketCap":680922085},{"date":"2025-01-31","current":-11.523339,"twenty":-12.794163,"median":-8.877425,"eighty":-6.150011,"marketCap":700722728},{"date":"2025-02-07","current":-12.070562,"twenty":-12.328345,"median":-8.905129,"eighty":-6.232886,"marketCap":733998807},{"date":"2025-02-14","current":-11.432889,"twenty":-12.292165,"median":-8.964497,"eighty":-6.236339,"marketCap":695222549},{"date":"2025-02-21","current":-11.279124,"twenty":-12.151063,"median":-8.998138,"eighty":-6.308164,"marketCap":685872246},{"date":"2025-02-28","current":-9.62841,"twenty":-12.079607,"median":-9.059485,"eighty":-6.342695,"marketCap":585493990},{"date":"2025-03-07","current":-10.297741,"twenty":-11.943932,"median":-9.320702,"eighty":-6.355126,"marketCap":626195310},{"date":"2025-03-14","current":-11.193196,"twenty":-11.879712,"median":-9.419648,"eighty":-6.365485,"marketCap":680647077},{"date":"2025-03-21","current":-14.554795,"twenty":-11.943932,"median":-9.482973,"eighty":-6.379634,"marketCap":724377586},{"date":"2025-03-28","current":-14.68208,"twenty":-12.421509,"median":-9.574004,"eighty":-6.398202,"marketCap":730712447},{"date":"2025-04-04","current":-12.728528,"twenty":-13.089934,"median":-9.668992,"eighty":-6.415901,"marketCap":633486102},{"date":"2025-04-11","current":-10.2603,"twenty":-12.90813,"median":-9.741473,"eighty":-6.42488,"marketCap":510644883},{"date":"2025-04-17","current":-12.761733,"twenty":-12.945214,"median":-9.779811,"eighty":-6.430405,"marketCap":635138674},{"date":"2025-04-25","current":-15.833323,"twenty":-13.271407,"median":-9.84549,"eighty":-6.435239,"marketCap":788008663},{"date":"2025-05-02","current":-15.982746,"twenty":-13.932929,"median":-9.940463,"eighty":-6.440764,"marketCap":795445305},{"date":"2025-05-09","current":-15.25222,"twenty":-14.136351,"median":-10.102399,"eighty":-6.452984,"marketCap":728141003},{"date":"2025-05-16","current":-16.118891,"twenty":-14.245886,"median":-10.138549,"eighty":-6.460191,"marketCap":769515850},{"date":"2025-05-23","current":-16.637714,"twenty":-14.356129,"median":-10.19625,"eighty":-6.460792,"marketCap":794284465},{"date":"2025-05-30","current":-17.410053,"twenty":-14.523491,"median":-10.236057,"eighty":-6.585104,"marketCap":831155927},{"date":"2025-06-06","current":-17.864023,"twenty":-14.65894,"median":-10.342966,"eighty":-6.96771,"marketCap":852828466},{"date":"2025-06-13","current":-17.439532,"twenty":-14.747436,"median":-10.384797,"eighty":-7.264924,"marketCap":832563235},{"date":"2025-06-20","current":-17.704839,"twenty":-14.88454,"median":-10.454615,"eighty":-7.299361,"marketCap":845229004},{"date":"2025-06-27","current":-17.752005,"twenty":-15.005667,"median":-10.623361,"eighty":-7.425628,"marketCap":847480696},{"date":"2025-07-03","current":-19.178768,"twenty":-15.33581,"median":-10.694071,"eighty":-7.451903,"marketCap":915594389},{"date":"2025-07-11","current":-20.198727,"twenty":-15.529319,"median":-10.766979,"eighty":-7.459202,"marketCap":964287236},{"date":"2025-07-18","current":-20.381494,"twenty":-15.833323,"median":-10.791578,"eighty":-7.484747,"marketCap":973012543},{"date":"2025-07-25","current":-19.691695,"twenty":-16.100113,"median":-11.044571,"eighty":-7.492045,"marketCap":940081543},{"date":"2025-08-01","current":-16.20487,"twenty":-16.158905,"median":-11.077981,"eighty":-7.667213,"marketCap":849102797},{"date":"2025-08-08","current":-17.484059,"twenty":-16.20487,"median":-11.141188,"eighty":-7.667213,"marketCap":916129723},{"date":"2025-08-15","current":-22.268769,"twenty":-16.33076,"median":-11.193196,"eighty":-7.674511,"marketCap":1166838947},{"date":"2025-08-22","current":-21.691773,"twenty":-16.434778,"median":-11.220775,"eighty":-7.693556,"marketCap":1136605525}],"updateTime":1756170231617},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LENZ\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2561497167","title":"BriaCell Therapeutics Says Board Approved Share Consolidation","url":"https://stock-news.laohu8.com/highlight/detail?id=2561497167","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561497167?lang=en_us&edition=fundamental","pubTime":"2025-08-22 01:01","pubTimestamp":1755795668,"startTime":"0","endTime":"0","summary":"BriaCell Therapeutics  said Thursday that its board has approved a share consolidation on the basis of one new share for every 10 currently outstanding shares to ensure continued compliance with the listing requirements of The Nasdaq Capital Market.The consolidation is subject to approval by the Nasdaq and the Toronto Stock Exchange, and is expected to become effective on Aug. 25, the company said.Price: 0.66, Change: -0.03, Percent Change: -4.48","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NQmain","BK4539","BK4139","BCTX","BK4007","LENZ"],"gpt_icon":0},{"id":"2561449785","title":"Dermata Therapeutics Is Maintained at Buy by Maxim Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2561449785","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561449785?lang=en_us&edition=fundamental","pubTime":"2025-08-22 00:41","pubTimestamp":1755794460,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DRMA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  August 21, 2025 12:41 ET (16:41 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DRMA","LENZ"],"gpt_icon":0},{"id":"2561951604","title":"Dianthus Therapeutics Is Maintained at Outperform by Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2561951604","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561951604?lang=en_us&edition=fundamental","pubTime":"2025-08-21 21:41","pubTimestamp":1755783660,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DNTH/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  August 21, 2025 09:41 ET (13:41 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DNTH","LENZ"],"gpt_icon":0},{"id":"2561934444","title":"Keros Therapeutics Shareholder ADAR1 Capital Urges Board to 'Work Collaboratively'","url":"https://stock-news.laohu8.com/highlight/detail?id=2561934444","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561934444?lang=en_us&edition=fundamental","pubTime":"2025-08-21 21:15","pubTimestamp":1755782142,"startTime":"0","endTime":"0","summary":"Keros Therapeutics'  largest stockholder ADAR1 Capital Management said Thursday it would like to \"work collaboratively\" with the board on strategy, capital allocation and potential board changes to unlock value for all shareholders.In an open letter, the shareholder, which holds around 13.3% of Keros' outstanding shares, said it was disappointed that the company's board refused to engage with it directly. ADAR1 also said it is seeking to meet with the company's independent directors as soon as possible.The investment manager urged the Keros board to provide a \"clear and detailed plan\" regarding the planned return of $375 million in excess capital announced on June 9.Although its preference is a collaboration with the board, ADAR1 said it would seek to elect new directors at the company's next annual meeting if the board continued to refuse its invitations to engage.Keros did not immediately reply to a request for comment from MT Newswires.Keros shares were down 1.5% in recent premarket","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","BK4007","BK4539","BK4139","KROS"],"gpt_icon":0},{"id":"2561460387","title":"Ocumension Therapeutics Reports Strong Revenue Growth Amid Product Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2561460387","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561460387?lang=en_us&edition=fundamental","pubTime":"2025-08-21 20:11","pubTimestamp":1755778306,"startTime":"0","endTime":"0","summary":"Ocumension Therapeutics ( ($HK:1477) ) just unveiled an update. Ocumension Therapeutics announced a 75.4% increase in revenue for the first half of...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ocumension-therapeutics-reports-strong-revenue-growth-amid-product-expansion?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ocumension-therapeutics-reports-strong-revenue-growth-amid-product-expansion?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ"],"gpt_icon":0},{"id":"2561642384","title":"Lisata Therapeutics Price Target Maintained With a $15.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2561642384","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561642384?lang=en_us&edition=fundamental","pubTime":"2025-08-21 19:29","pubTimestamp":1755775740,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LSTA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  August 21, 2025 07:29 ET (11:29 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LSTA","LENZ"],"gpt_icon":0},{"id":"2561641734","title":"Trevi Therapeutics Initiated at Overweight by Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2561641734","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561641734?lang=en_us&edition=fundamental","pubTime":"2025-08-21 19:26","pubTimestamp":1755775560,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TRVI/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  August 21, 2025 07:26 ET (11:26 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRVI","LENZ"],"gpt_icon":0},{"id":"2561346921","title":"Wedbush Raises Price Target on Dianthus Therapeutics to $42 From $34, Keeps Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2561346921","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561346921?lang=en_us&edition=fundamental","pubTime":"2025-08-21 18:53","pubTimestamp":1755773627,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics (DNTH) has an average rating of buy and mean price target of $51.78, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from maj","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DNTH","LENZ"],"gpt_icon":0},{"id":"2561651834","title":"Werewolf Therapeutics price target lowered to $3 from $4 at Citizens JMP","url":"https://stock-news.laohu8.com/highlight/detail?id=2561651834","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561651834?lang=en_us&edition=fundamental","pubTime":"2025-08-21 17:45","pubTimestamp":1755769512,"startTime":"0","endTime":"0","summary":"Citizens JMP lowered the firm’s price target on Werewolf Therapeutics (HOWL) to $3 from $4 and keeps an Outperform rating on the shares. With impor...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/werewolf-therapeutics-price-target-lowered-to-3-from-4-at-citizens-jmp-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/werewolf-therapeutics-price-target-lowered-to-3-from-4-at-citizens-jmp-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","JMP","HOWL"],"gpt_icon":0},{"id":"2561463400","title":"IRLAB Therapeutics Appoints Roy Jonebrant as Interim CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2561463400","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561463400?lang=en_us&edition=fundamental","pubTime":"2025-08-21 17:36","pubTimestamp":1755768973,"startTime":"0","endTime":"0","summary":"IRLAB Therapeutics AB Class A ( ($SE:IRLAB.A) ) has issued an announcement. IRLAB Therapeutics AB has appointed Roy Jonebrant as interim CFO, effec...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/irlab-therapeutics-appoints-roy-jonebrant-as-interim-cfo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/irlab-therapeutics-appoints-roy-jonebrant-as-interim-cfo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LENZ","BK4007","BK4539"],"gpt_icon":0},{"id":"2561175463","title":"Trevi Therapeutics initiated with an Overweight at Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2561175463","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561175463?lang=en_us&edition=fundamental","pubTime":"2025-08-21 17:20","pubTimestamp":1755768008,"startTime":"0","endTime":"0","summary":"Morgan Stanley analyst Judah Frommer initiated coverage of Trevi Therapeutics (TRVI) with an Overweight rating and $18 price target The company is ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/trevi-therapeutics-initiated-with-an-overweight-at-morgan-stanley-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/trevi-therapeutics-initiated-with-an-overweight-at-morgan-stanley-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ"],"gpt_icon":0},{"id":"1166771254","title":"Goldman Sachs Reviews Viking Therapeutics (VKTX.US) Oral Drug VK2735 Trial Results: Significant Efficacy but Questionable Tolerability, Better Suited for Weight Maintenance","url":"https://stock-news.laohu8.com/highlight/detail?id=1166771254","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166771254?lang=en_us&edition=fundamental","pubTime":"2025-08-21 16:32","pubTimestamp":1755765169,"startTime":"0","endTime":"0","summary":"Goldman Sachs released a commentary report this week regarding Viking Therapeutics' (VKTX.US) recent trial results and mentioned potential impacts on Eli Lilly (LLY.US). Recently, Viking Therapeutics...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0096364046.USD","BK4504","BK4599","LU2237443465.HKD","BK4127","BK4550","LU1894683264.USD","LU2237443382.USD","LU1894683348.USD","LU2237443978.SGD","LU1868836757.USD","LU2471134879.HKD","IE00B19Z3581.USD","IE0004091025.USD","VKTX","LU2471134523.USD","LENZ","BK4007","IE00BFXG1179.USD","LU0251131958.USD","LU2237443622.USD","LU1868836591.USD","BK4533","BK4539","LU2237443895.HKD","LU2750360997.AUD","IE0004086264.USD","BK4139","LU2237438978.USD","LU0048573561.USD","LU1791807156.HKD","LU0106831901.USD","LU1868837136.USD","LU2471134952.CNY","LU2750360641.GBP","IE00BSNM7G36.USD","BK4552","LU2237443549.SGD","LU0061475181.USD","LU1668664300.SGD","LU1868836914.USD","LU1868837300.USD","BK4516","IE00B19Z3B42.SGD","IE0034235188.USD","IE0002270589.USD","BK4588","BK4585","LU0742534661.SGD","LU2471134796.USD","LU0251142724.SGD"],"gpt_icon":1},{"id":"2561452848","title":"Chimeric Therapeutics Director Acquires Significant Shareholding","url":"https://stock-news.laohu8.com/highlight/detail?id=2561452848","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561452848?lang=en_us&edition=fundamental","pubTime":"2025-08-21 15:35","pubTimestamp":1755761755,"startTime":"0","endTime":"0","summary":"Chimeric Therapeutics Ltd. ( ($AU:CHM) ) has provided an announcement. Chimeric Therapeutics Limited has announced a change in the director’s inter...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/chimeric-therapeutics-director-acquires-significant-shareholding?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/chimeric-therapeutics-director-acquires-significant-shareholding?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2561592459","title":"Tryptamine Therapeutics Enters Exclusive Agreement for Development of Proprietary Electroencephalogram-Based Biomarker Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2561592459","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561592459?lang=en_us&edition=fundamental","pubTime":"2025-08-21 14:43","pubTimestamp":1755758586,"startTime":"0","endTime":"0","summary":"Tryptamine Therapeutics (ASX:TYP) entered into an exclusive biomarker development agreement with Robin Carhart-Harris, the Chair of the firm's scientific advisory board and Pedro Mediano, a professor ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","LENZ","BK4007","BK7096","TYP.AU","BK4539"],"gpt_icon":0},{"id":"2561469159","title":"Private equity firms in Ocumension Therapeutics (HKG:1477) are its biggest bettors, and their bets paid off as stock gained 5.5% last week","url":"https://stock-news.laohu8.com/highlight/detail?id=2561469159","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561469159?lang=en_us&edition=fundamental","pubTime":"2025-08-21 13:21","pubTimestamp":1755753693,"startTime":"0","endTime":"0","summary":"SEHK:1477 1 Year Share Price vs Fair Value Explore Ocumension Therapeutics's Fair Values from the Community and select...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1477/ocumension-therapeutics-shares/news/private-equity-firms-in-ocumension-therapeutics-hkg1477-are","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1574","BK4007","BK4539","LENZ","BK4139","01477","BK1191"],"gpt_icon":0},{"id":"2561370144","title":"Tryptamine Therapeutics Announces Proposed Issue of Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2561370144","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561370144?lang=en_us&edition=fundamental","pubTime":"2025-08-21 11:48","pubTimestamp":1755748082,"startTime":"0","endTime":"0","summary":"Tryptamine Therapeutics ( ($AU:TYP) ) just unveiled an announcement. Tryptamine Therapeutics Limited has announced a proposed issue of 2,000,000 un...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tryptamine-therapeutics-announces-proposed-issue-of-securities?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tryptamine-therapeutics-announces-proposed-issue-of-securities?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2561057484","title":"Silexion Therapeutics Executes Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2561057484","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561057484?lang=en_us&edition=fundamental","pubTime":"2025-08-21 05:19","pubTimestamp":1755724748,"startTime":"0","endTime":"0","summary":"Silexion Therapeutics ( ($SLXN) ) has shared an announcement. On July 28, 2025, Silexion Therapeutics Corp implemented a 1-for-15 reverse share spl...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/silexion-therapeutics-executes-reverse-stock-split?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/silexion-therapeutics-executes-reverse-stock-split?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4007","BK4539","BK4139"],"gpt_icon":0},{"id":"2561048467","title":"Trevi Therapeutics CFO Resignation Announced","url":"https://stock-news.laohu8.com/highlight/detail?id=2561048467","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561048467?lang=en_us&edition=fundamental","pubTime":"2025-08-21 05:00","pubTimestamp":1755723618,"startTime":"0","endTime":"0","summary":"Trevi Therapeutics ( ($TRVI) ) has issued an announcement. On August 14, 2025, Trevi Therapeutics announced that its Chief Financial Officer, Lisa ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/trevi-therapeutics-cfo-resignation-announced?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/trevi-therapeutics-cfo-resignation-announced?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","LENZ","BK4007"],"gpt_icon":0},{"id":"2561481750","title":"Oruka Therapeutics initiated with a Buy at Clear Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2561481750","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561481750?lang=en_us&edition=fundamental","pubTime":"2025-08-21 04:35","pubTimestamp":1755722116,"startTime":"0","endTime":"0","summary":"Clear Street analyst Kaveri Pohlman initiated coverage of Oruka Therapeutics (ORKA) with a Buy rating and $46 price target The firm views the stock...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/oruka-therapeutics-initiated-with-a-buy-at-clear-street-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/oruka-therapeutics-initiated-with-a-buy-at-clear-street-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4007","LENZ","ORKA","BK4539"],"gpt_icon":0},{"id":"1192236024","title":"Windtree Therapeutics to Be Delisted from NASDAQ for Failing to Meet Minimum Closing Price Standards","url":"https://stock-news.laohu8.com/highlight/detail?id=1192236024","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192236024?lang=en_us&edition=fundamental","pubTime":"2025-08-21 02:31","pubTimestamp":1755714689,"startTime":"0","endTime":"0","summary":"Windtree Therapeutics, dubbed the \"BNB MicroStrategy\" company, received notification from NASDAQ on August 19, 2025, that its common stock will be delisted from the NASDAQ Capital Market on August 21...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDX","LENZ","QID","ARTL","MNQmain","USAW.SI",".IXIC","BK1147","PSQ","BK4139","USJW.SI","BK4539","NQmain","TSYW.SI","SQQQ","QLD","BK4007","QQQ","03086","TQQQ","159632","NVIW.SI"],"gpt_icon":1}],"pageSize":20,"totalPage":17,"pageCount":3,"totalSize":322,"code":"91000000","status":"200"}]}}